Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus infections. The Lancet, 357(9267), 1513-1518.
Johnston, C., Gottlieb, S. L., & Wald, A. (2016). Status of vaccine research and development of vaccines for herpes simplex virus. Vaccine, 34(26), 2948-2952.
Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Newman, L. M., & Gottlieb, S. L. (2015). Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One, 10(10), e0140765.
James, C., Harfouche, M., Welton, N. J., Turner, K. M. E., Abu-Raddad, L. J., Gottlieb, S. L., & Looker, K. J. (2020). Herpes simplex virus: Global infection prevalence and incidence estimates, 2016. Bulletin of the World Health Organization, 98(5), 315-329.
Fatahzadeh, M., & Schwartz, R. A. (2007). Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology, 57(5), 737-763.
Tran, T., Flynn, C., & Urgoiti, G. (2018). Systematic review and meta-analysis of the efficacy and safety of valacyclovir versus acyclovir for the treatment of herpes zoster. BMC Infectious Diseases, 18(1), 352.
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A. G., & Hayes, R. J. (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS, 20(1), 73-83.
Gnann, J. W., & Whitley, R. J. (2016). Genital herpes. New England Journal of Medicine, 375(7), 666-674.
Tronstein, E., Johnston, C., Huang, M. L., Selke, S., Magaret, A., Warren, T., … & Wald, A. (2011). Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA, 305(14), 1441-1449.
Awasthi, S., Friedman, H. M., & Awasthi, S. (2019). Vaccine approaches for herpes simplex virus types 1 and 2. Microorganisms, 7(11), 543.